A new research paper was published in Volume 16 of Genes & Cancer on January 20, 2025, entitled, "Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation." ...

In a party-line vote last evening, the U.S. Senate confirmed Stanford professor and medical researcher Jay Bhattacharya as director of the National Institutes of Health (NIH). The confirmation of ...

Disease X is an unknown pathogen capable of causing a devastating pandemic. This term was coined by the World Health Organization in 2018 and was under discussion at the World Economic Forum in Davos, ...

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, "The Gain-of-Function ...

Section 1. Purpose. Dangerous gain-of-function research on biological agents and pathogens has the potential to significantly endanger the lives of American citizens. If left unrestricted, its effects ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The system of long noncoding RNA (lncRNA)–mediated transcriptional interference that represses fission yeast phosphate homoeostasis gene pho1 provides a sensitive readout of genetic influences on ...

On May 5, 2025, President Donald Trump signed an executive order with the seemingly benign title, “Improving the Safety and Security of Biological Research.” A more accurate title would have been, ...

Gain Therapeutics’ phase 1 drug for Parkinson’s disease associated with a common gene mutation appears to restore motor function in mice, even after a delay between symptom onset and treatment, new ...